Physician profile
Pawan Grover
NPI 1801889555
$10,294.76
in general payments reported to CMS, 2019-2025
30 companies · $2,033 in 2025
The $2,033 reported for 2025 was more than what 79% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $247 · 2021: $517 · 2022: $4,238 · 2023: $1,788 · 2024: $1,223 · 2025: $2,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,983 · Education: $60.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,983.28 |
| Education | $60.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,395.60 | 2021-2025 | Proclaim, Eterna |
| Mml US, INC. | $1,960.64 | 2022-2023 | Reactiv8 |
| Spinal Simplicity, LLC | $932.28 | 2022 | |
| Medtronic, INC. | $537.46 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nalu Medical, INC. | $477.63 | 2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $255.42 | 2025 | Evoke |
| Painteq LLC | $209.56 | 2022-2024 | Painteq |
| Genesys Orthopedics Systems, L.L.C. | $198.82 | 2021 | |
| Stimwave Technologies Incorporated | $193.44 | 2019 | |
| Boston Scientific Corporation | $155.01 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $129.63 | 2024 | Senza |
| Si-Bone, INC. | $114.55 | 2022-2025 | |
| Medtronic USA, INC. | $113.21 | 2019-2020 | |
| Globus Medical, INC. | $81.62 | 2025 | Senza |
| Biotronik Nro, INC. | $65.84 | 2025 | Prospera |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.24 | 2020 | |
| Azurity Pharmaceuticals, INC. | $46.55 | 2024 | Horizant |
| Vertos Medical, INC. | $46.16 | 2023 | Mild Device Kit |
| Bioventus LLC | $44.02 | 2023-2024 | Gelsyn-3 |
| Abbvie INC. | $43.27 | 2022-2023 | |
| Electronic Waveform Lab, INC. | $40.10 | 2021 | |
| Grt US Holding, INC. | $33.33 | 2020 | |
| Innovation Technologies INC | $28.20 | 2024 | Irrisept |
| Horizon Therapeutics Plc | $24.35 | 2023 | Krystexxa |
| Biohaven Pharmaceuticals, INC. | $20.76 | 2021 | |
| Ibsa Pharma INC. | $20.31 | 2025 | Tirosint, Licart, Flector |
| Pacira Therapeutics, INC. | $20.29 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.73 | 2022 | |
| Fidia Pharma USA INC. | $16.74 | 2025 | Hymovis |
| Elutia, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pawan Grover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.